Arpida, Research & Development of Anti-Infectives

Home

Search | Sitemap | Print

Arpida Ltd. (SWX: ARPN) is a Swiss biopharmaceutical company that focuses on novel products for the treatment of microbial infections.

Click here for our latest press release:

December 19, 2008
Arpida publishes top-line data of phase II “intravenous-to-oral” switch trial with oral iclaprim

Download press release (pdf) English German French

Press Releases

December 19, 2008
Arpida publishes top-line data of phase II “intravenous-to-oral” switch trial with oral iclaprim

December 16, 2008
Arpida implements comprehensive action plan

November 27, 2008
Arpida to restructure and focus on key projects

November 20, 2008
Arpida Comments on FDA’s Anti-infective Drugs Advisory Committee Outcome

October 26th, 2008

October 14th, 2008
Arpida announces review of iclaprim NDA by FDA Advisory Committee in November 2008

[ more ... ]

Arpida – Research & Development of Anti-Infectives